Here NIAID sets fiscal year (FY) 2025 funding levels for new competing awards, renewals, and noncompeting awards. We update this page and the NIAID Paylines every FY.
Our most recent update was on November 7, 2024: We added research project grant (R01) awards for new and early-stage investigators to the list of competing awards that will be funded with no reduction to the approved funding level. NIH does not have an appropriation for FY 2025; NIH is operating under a continuing resolution through March 14, 2025.
Competing Awards
- Competing investigator-initiated awards will be funded at 97 percent of approved funding level. This excludes fellowship (F), training (T), career development (K), small business (SBIR/STTR), research project grant (R01) for new and early-stage investigators, research conference grant (R13), and Method to Extend Research in Time (R37) awards, and awards funded with non-direct appropriations (e.g., supplemental appropriations) or appropriations specifically directed by Congress, which will be funded with no reduction to the approved funding level.
- Multiyear awards will be funded at 97 percent of approved funding level for all years.
- Funds available for each extramural division’s solicited portfolio will be reduced by 3 percent overall from the approved funding level. This may involve a reduction in the number of awards or a reduction in the award amount for any notice of funding opportunity.
- Upward adjustments to awarded levels will be considered after FY 2025 appropriations are enacted.
- Renewal budgets for R01s are capped at 20 percent over the direct costs of the last noncompeting award, not including equipment or alterations and renovations costs. For a competing R01 renewal grant, NIAID will fund at 97 percent of approved funding level after applying the renewal budget cap.
- Salaries are limited to the levels published on Salary Cap, Stipends, & Training Funds.
Noncompeting Awards
- Noncompeting continuation (Type 5, Type 8) and extension (Type 4) awards will be funded at 97 percent of the FY 2025 committed level. This excludes Fs, Ts, Ks, SBIRs/STTRs, research transition awards (R00), R13, R37, and awards funded with non-direct appropriations (e.g., supplemental appropriations) or appropriations specifically directed by Congress.
- Upward adjustments to awarded levels will be considered after FY 2025 appropriations are enacted.
- Salaries are limited to the levels published on Salary Cap, Stipends, & Training Funds.
We will post additional financial management plan information as it becomes available.
More Information
For NIH’s most recent announcement about legislative mandates, refer to the April 30, 2024 Guide notice. NIH posts financial plan information at NIH Extramural Financial Operations.
Check this page and NIAID Funding News for updates.
Go to NIAID Paylines & Funding for the latest Paylines, how NIAID Paylines and Budget Information Changes Throughout the Year, and more.